Question 1

Am I eligible for this trial based on my mental health history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure clinical trial (NCT02648165). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the Attention Bias Modification work, and what can I expect during the sessions?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure clinical trial (NCT02648165). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure clinical trial (NCT02648165). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my progress be monitored during and after the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure clinical trial (NCT02648165). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure clinical trial (NCT02648165). Contact the study team or your healthcare provider for specific answers.

Question 6

What other treatment options are available if I do not participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Secondary Prevention of Depression Through Group-based ACT-Therapy Preceded by an Experimental ABM-Procedure clinical trial (NCT02648165). Contact the study team or your healthcare provider for specific answers.

What this study is about